Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pediatric Anthracycline‐Induced Cardiotoxicity: Mechanisms, Pharmacogenomics, and Pluripotent Stem‐Cell Modeling
Anne Tripaydonis, Rachel Conyers, David A. Elliott
Clinical Pharmacology & Therapeutics (2018) Vol. 105, Iss. 3, pp. 614-624
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
Alessandra Murabito, Emilio Hirsch, Alessandra Ghigo
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 81
Cardiac Disease in Childhood Cancer Survivors
Jan M. Leerink, Esmée C. de Baat, Elizabeth A. M. Feijen, et al.
JACC CardioOncology (2020) Vol. 2, Iss. 3, pp. 363-378
Open Access | Times Cited: 72
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes
Hananeh Fonoudi, Mariam Jouni, Romina B. Cejas, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 1, pp. 38-50
Open Access | Times Cited: 15
Anticancer therapy-induced adverse drug reactions in children and preventive and control measures
Hui Yan, Penggao Wang, Fang Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Efficacy of Dexrazoxane in Cardiac Protection in Pediatric Patients Treated With Anthracyclines
Parya Rahimi, Behsheed Barootkoob, Ahmed ElHashash, et al.
Cureus (2023)
Open Access | Times Cited: 18
Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review
Omar Cauli
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1116-1116
Open Access | Times Cited: 31
Cardiotoxicity: A Major Setback in Childhood Leukemia Treatment
Diana Raluca Lazar, Anca Daniela Fărcaș, Cristina Blag, et al.
Disease Markers (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 28
Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials
Mei Zhao, Xiaohong Zhang, Dongyang Zhou, et al.
Open Access Journal of Clinical Trials (2025) Vol. Volume 17, pp. 1-14
Open Access
Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
Rui Liu, Dong Li, Fangxu Sun, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity
Yonghe Ding, Ke Du, Yujuan Niu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 13
Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane
Nicoletta Bertorello, Roberto Luksch, Gianni Bisogno, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 9
Closed Access | Times Cited: 7
Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity
Angela Siemens, Shahrad R. Rassekh, Colin J.D. Ross, et al.
Therapeutic Drug Monitoring (2023)
Closed Access | Times Cited: 6
Correlation of Speckle-Tracking Echocardiography with Traditional Biomarkers in Predicting Cardiotoxicity among Pediatric Hemato-Oncology Patients: A Comprehensive Evaluation of Anthracycline Dosages and Treatment Protocols
Andrada Mara Ardelean, Ioana Cristina Olariu, Raluca Isac, et al.
Children (2023) Vol. 10, Iss. 9, pp. 1479-1479
Open Access | Times Cited: 6
Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia
Jesús Alonso Gándara-Mireles, Ismael Lares‐Asseff, Elio Aarón Reyes Espinoza, et al.
Pharmacogenetics and Genomics (2021) Vol. 31, Iss. 5, pp. 108-115
Closed Access | Times Cited: 14
Diquat Herbicide Organophosphate Poisoning and Multi-Organ Failure: A Case Report
Daniel M Aloise, Adam Memon, Ana Zaldivar
Cureus (2022)
Open Access | Times Cited: 9
Review of nutritional status, body composition, and effects of antineoplastic drug disposition
John Wiernikowski, M. Brooke Bernhardt
Pediatric Blood & Cancer (2020) Vol. 67, Iss. S3
Open Access | Times Cited: 13
Risk Factors of Daunorubicine Induced Early Cardiotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Study
Sunny Mariana Samosir, I Ketut Alit Utamayasa, Mia Ratwita Andarsini, et al.
Asian Pacific Journal of Cancer Prevention (2021) Vol. 22, Iss. 5, pp. 1407-1412
Open Access | Times Cited: 12
Genetic factors in anthracycline-induced cardiotoxicity in patients treated for pediatric cancer
Kateryna Petrykey, Grégor Andelfinger, Caroline Laverdière, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 10, pp. 865-883
Closed Access | Times Cited: 12
Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
Timothy N. McOwan, Lauren Craig, Anne Tripdayonis, et al.
Cardio-Oncology (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 11
Cardiovascular and Pulmonary Challenges After Treatment of Childhood Cancer
Henk Visscher, Maria Otth, Elizabeth A. M. Feijen, et al.
Pediatric Clinics of North America (2020) Vol. 67, Iss. 6, pp. 1155-1170
Closed Access | Times Cited: 11
Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Mo-Fan Huang, Lon Kai Pang, Yi‐Hung Chen, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2823-2823
Open Access | Times Cited: 10
Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients
Jessica Liliana Vargas Neri, Bruce Carleton, Colin J.D. Ross, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 5, pp. 291-301
Closed Access | Times Cited: 7
Novel Biomarkers of Heart Failure in Pediatrics
Teja Senekovič Kojc, Nataša Marčun Varda
Children (2022) Vol. 9, Iss. 5, pp. 740-740
Open Access | Times Cited: 7
Pediatric Chemotherapy Drugs Associated With Cardiotoxicity
Gazala Hitawala, Esha Jain, Lisett Castellanos, et al.
Cureus (2021)
Open Access | Times Cited: 9
Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs
Ignacio Reinal, Imelda Ontoria‐Oviedo, Marta Selva, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1378-1378
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top